[
    [
        {
            "time": "2019-01-02",
            "original_text": "Moody's assigns Baa1 senior unsecured rating to Danaher's new notes",
            "features": {
                "keywords": [
                    "Moody's",
                    "Baa1",
                    "senior unsecured",
                    "rating",
                    "Danaher"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "finance"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "Moody's assigns Baa1 senior unsecured rating to Danaher's new notes",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2019-01-03",
            "original_text": "Danaher initiates stock sale to help finance $21B GE Biopharma acquisition",
            "features": {
                "keywords": [
                    "Danaher",
                    "stock sale",
                    "finance",
                    "GE Biopharma",
                    "acquisition"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare",
                    "finance"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 9,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 5
            }
        },
        {
            "time": "2019-09-06",
            "original_text": "Northrop Grumman Corporation (NOC) Ex-Dividend Date Scheduled for September 06, 2019",
            "features": {
                "keywords": [
                    "Northrop Grumman",
                    "Ex-Dividend Date",
                    "Scheduled"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "defense"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 7,
                "Entity_Density": 7,
                "Market_Scope": 2,
                "Time_Proximity": 5,
                "Headline_Structure": 5,
                "Source_Recency": 4
            }
        }
    ]
]